Abstract
Celiac disease, an immune-mediated condition related to gluten sensitivity, is gaining pharmaceutical development interest. Recent conversations with the US Food and Drug Administration (FDA) indicate pathology readouts from intestinal biopsies will continue to be a primary clinical trial endpoint. The existing methodology, the Marsh-Oberhuber score, is a qualitative assessment of celiac severity, combining a morphological criterion known as villous height to crypt depth ratio (VC), with an assessment of localized immune response, manually estimating intraepithelial lymphocyte (IEL) counts. A stereology and image analysis based whole slide imaging methodology was developed for use in CLIA-based clinical trials. Experimental Design: A series of ten normal and ten abnormal patient small bowel biopsies were manually evaluated by two pathologists to determine celiac disease (CD) state using the standard Marsh score. Two quantitative methods were developed—an automated stereological methodology was used to evaluate surface area on whole slide images and an image analysis complementary approach. Methods: Stereology line probes were used to count one-dimensional “hits” on points at the distal ends of the lines which exist over reference tissue area, and “cuts” through the two-dimensional range of the line as it passes through the epithelium of the reference tissue to background, or vice versa. Results: There was strong concordance between the pathologist scores, and the automated stereology analysis, with the automated approaches able to sufficiently delineate intermediate grades of disease, normally more difficult in visual assessments. Conclusion: The quantitative methodology is a valuable addition to CLIA-based clinical trials. Quantitation provides reproducible and unbiased endpoints that can evaluate both the morphological and immune response in therapeutic clinical studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Rampertab SD, Mullins GE (eds) (2014) Celiac disease. Humana Press, New York
Rubio-Tapia A, Ludvigsson JF (2012) The prevalence of celiac disease in the United States. Am J Gastroenterol 107:1538–1544
Catassi C, Fasano A (2010) Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 123(8):691–693
Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11(10):1185–1194
Lewis NR, Holmes GK (2010) Risk of morbidity in contemporary celiac disease. Expert Rev Gastroenterol Hepatol 4(6):767–780
Lähdeaho M-L, Kaukinen K, Laurila K et al (2014) Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology 146(7):1649–1658
Kelly CP, Green PHR (2013) Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomized placebo-controlled study. Aliment Pharmacol Ther 37(2):252–262
United States Food & Drug Administration (2014) Conference presentation: drug development in celiac disease: FDA perspective Jessica Lee – United States Food & Drug Administration, USA. Presented at development of therapies for celiac disease, 20–21 March 2014
Corazza GR, Villanacci V (2005) Coeliac disease. J Clin Pathol 58:573–574
Risdon RA, Keeling JW (1974) Quantitation of the histological changes found in small intestinal biopsy specimens from children with suspected coeliac disease. Gut 15:9–18
Howard CV, Reed MG (2005) Unbiased stereology. Garland Science, New York
Wright SG, Tomkins AM (1978) Quantitative histology in giardiasis. J Clin Pathol 31:712–716
Taavela J, Koskinen O, Huhtala H et al (2013) Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One 8(10):e76163
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hagendorn, E., Whitney-Miller, C., Huber, A., Potts, S.J. (2014). Development of a Tissue Image Analysis Algorithm for Celiac Drug Development. In: Potts, S., Eberhard, D., Wharton, Jr., K. (eds) Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/7653_2014_25
Download citation
DOI: https://doi.org/10.1007/7653_2014_25
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2680-0
Online ISBN: 978-1-4939-2681-7
eBook Packages: Springer Protocols